首页 工具
登录
购物车
Geldanamycin

Geldanamycin

产品编号 T6343   CAS 30562-34-6
别名: 格尔德霉素, NSC 122750

Geldanamycin 是一种 HSP90 抑制剂(Kd:1.2 μM),可特异性破坏糖皮质激素受体 (GR)/HSP 的结合。

TargetMol的所有产品和服务仅用于科学研究,不能被用于人体,我们也不向个人提供产品和服务。
Geldanamycin Chemical Structure
Geldanamycin, CAS 30562-34-6
规格 价格/CNY 货期 数量
1 mg ¥ 413 现货
2 mg ¥ 593 现货
5 mg ¥ 987 现货
10 mg ¥ 1,650 现货
25 mg ¥ 2,750 现货
50 mg ¥ 3,970 现货
100 mg ¥ 5,790 现货
1 mL * 10 mM (in DMSO) ¥ 1,280 现货
产品目录号及名称: Geldanamycin (T6343)
点击图片重新获取验证码
选择批次  
更多批次查询请联系客服
天然产物信息
生物活性
化学信息
存储 & 溶解度
参考文献
产品描述 Geldanamycin, an HSP90 inhibitor (Kd: 1.2 μM), specifically disrupts glucocorticoid receptor (GR)/HSP association.
靶点活性 HSP90 (N-terminal domain):0.78 μM(Kd), HSP90:1.2 μM(Kd), p185:70 nM
体外活性 Geldanamycin binds in the ATP-binding site in the N-terminus domain of Hsp90s (residues 1-220). Geldanamycin inhibits the ATPase activity of Hsp90 in a dose-dependent manner. [1] Geldanamycin causes a dose-dependent G2 arrest and reversible inhibiton o f entry into the S phase in A2780 human ovarian cell line. This inhibition is accompanied by p53 increase and finally demonstrated to be p53 dependent. [2] Geldanamycin causes polyubiquitination and proteasomal degradation of the p185 receptor protein-tyrosin kinase and shows a IC50 with 70 nM. [3, 4] Geldanamycin is a typical anti-tumor reagent, shows a mean GI50 with 0.18 μM against the panel of 60 human tumor cell lines. [5]
体内活性 Geldanamycin (50 mg//kg) shows 30% inhibition on pl85-associated phosphotyrosine levels in FRE/erbB-2 mice. [6]
激酶实验 Isothermal Titration Calorimetry (ITC) of Nucelotide Binding: The titration experiments are performed using the MSC system. In each experiment, 16 aliquots of 15 μL of geldanamycin (300 μM in 1% DMSO) are injected into 1.3 mL of protein (31 μM in 20 mMTris-HCl, pH 7.5, 1 mMEDTA) at 25 °C, and the resulting data are fit after subtracting the heats of dilution. Heats of dilution are determined in separate experiments from addition of geldanamycin into buffer and buffer into protein. No evidence for binding of DMSO in the nucleotide binding site is observed. Titration data are fit using a nonlinear least-squares curve-fitting algorithm with three floating variables: stoichiometry, binding constant (Kb) 1/Kd), and change of enthalpy of interaction (ΔH°). Dissociation constants estimated for geldanamycin binding to intact yeast Hsp90 is 1.22 μM, and for binding to Hsp90 N-terminal domain is 0.78 μM. No meaningful heat is observed with binding to the C-terminal fragment.
细胞实验 Exponentially growing cells are treated with Geldanamycin and at various times DNA synthesis is assessed by incorporation of bromodeoxyuridine (BrdUrd) and flow cytometric analysis. No marked difference in total cell number is noted during this time course for treated and untreated cultures. BrdUrd (10 μM) is incorporated over a 4-h incubation period at 37 °C and cells are harvested and fixed in 70% ethanol. After denaturation of the DNA with 2 N HC1, cells are incubated with an anti-BrdUrd mouse monoclonal antibody followed by a fluorescein isothiocyanate (FITC)-linked goat anti-mouse IgG. Cells are stained for 30 minutes at room temperature with propidium iodide and analysed by flow cytometry using a Coulter EPICS Profile Analyzer. (Only for Reference)
别名 格尔德霉素, NSC 122750
分子量 560.64
分子式 C29H40N2O9
CAS No. 30562-34-6

存储

Powder: -20°C for 3 years | In solvent: -80°C for 1 year

溶解度

DMSO: 50 mg/mL (89.18 mM), warmed

H2O: < 1 mg/mL (insoluble or slightly soluble)

Ethanol: < 1 mg/mL (insoluble or slightly soluble)

溶液配制表

可选溶剂 浓度 体积 质量 1 mg 5 mg 10 mg 25 mg
DMSO 1 mM 1.7837 mL 8.9184 mL 17.8368 mL 44.5919 mL
5 mM 0.3567 mL 1.7837 mL 3.5674 mL 8.9184 mL
10 mM 0.1784 mL 0.8918 mL 1.7837 mL 4.4592 mL
20 mM 0.0892 mL 0.4459 mL 0.8918 mL 2.2296 mL
50 mM 0.0357 mL 0.1784 mL 0.3567 mL 0.8918 mL

计算器

摩尔浓度计算器
稀释计算器
配液计算器
分子量计算器
=
X
X
X
=
X
=
/
g/mol

输入分子式,点击计算,可计算出产品的分子量。

参考文献

1. Roe SM, et al, J Med Chem, 1999, 42(2), 260-266. 2. Mcllwrath AJ, et al, Cancer Chemother Pharmacol, 1996, 37(5), 423-428. 3. Mimnaugh EG, et al, J Biol Chem 1996, 271(37), 22796-22801. 4. Miller P, et al, Cancer Res, 1994, 54(10), 2724-2730. 5. Supko JG, et al, Cancer Chemother Pharmacol, 1995, 36(4), 305-315. 6. Lin Z, et al. 17-ABAG, a novel Geldanamycin derivative, inhibits LNCaP-cell proliferation through heat shock protein 90 inhibition. Int J Mol Med. 2015 Aug;36(2):424-32. 7. Tang HB, et al. Viperin inhibits rabies virus replication via reduced cholesterol and sphingomyelin and is regulated upstream by TLR4. Sci Rep. 2016 Jul 26;6:30529 8. Siddiqui F A, Parkkola H, Vukic V, et al. Novel Small Molecule Hsp90/Cdc37 Interface Inhibitors Indirectly Target K-Ras-Signaling[J]. Cancers. 2021, 13(4): 927. 9. Díaz-Díaz A, Roca-Lema D, Casas-Pais A, et al. Heat Shock Protein 90 Chaperone Regulates the E3 Ubiquitin-Ligase Hakai Protein Stability[J]. Cancers. 2020, 12(1): 215. 10. Wu Z, Geng Y, Lu X, et al. Chaperone-mediated autophagy is involved in the execution of ferroptosis[J]. Proceedings of the National Academy of Sciences. 2019 Feb 19;116(8):2996-3005.

文献引用

1. Siddiqui F A, Parkkola H, Manoharan G B, et al. Medium-Throughput Detection of Hsp90/Cdc37 Protein-Protein Interaction Inhibitors Using a Split Renilla Luciferase-Based Assay. SLAS DISCOVERY: Advancing the Science of Drug Discovery. 2020, 25(2): 195-206 2. Wu Z, Geng Y, Lu X, et al. Chaperone-mediated autophagy is involved in the execution of ferroptosis. Proceedings of the National Academy of Sciences. 2019 Feb 19;116(8):2996-3005 3. Díaz-Díaz A, Roca-Lema D, Casas-Pais A, et al. Heat Shock Protein 90 Chaperone Regulates the E3 Ubiquitin-Ligase Hakai Protein Stability. Cancers. 2020, 12(1): 215 4. Siddiqui F A, Parkkola H, Vukic V, et al. Novel Small Molecule Hsp90/Cdc37 Interface Inhibitors Indirectly Target K-Ras-Signaling. Cancers. 2021 Feb 23;13(4):927. doi: 10.3390/cancers13040927. 5. Wei Shi, Guang Xu, Xiaoyan Zhan, Yuan Gao, Zhilei Wang, Shubin Fu, Nan Qin, Xiaorong Hou, Yongqiang Ai, Chunyu Wang, Tingting He, Hongbin Liu, Yuanyuan Chen, Yan Liu, Jiabo Wang, Ming Niu, Yuming Guo, Xiaohe Xiao & Zhaofang Bai Carnosol inhibits inflammasome activation by directly targeting HSP90 to treat inflammasome-mediated diseases. Cell Death & Disease. 2020 6. Siddiqui F A, Parkkola H, Manoharan G, et al. Medium-Throughput Detection of Hsp90/Cdc37 Protein–Protein Interaction Inhibitors Using a Split Renilla Luciferase-Based Assay. SLAS Discovery. 2020, 25(2): 195-206
Cerdulatinib hydrochloride ST271 NVP-BSK805 2HCl (1092499-93-8(free base)) NVP-AEW541 Paltimatrectinib Tafetinib Ilginatinib maleate AZ7550

相关化合物库

该产品包含在如下化合物库中:
微生物天然产物库 抗癌活性化合物库 酪氨酸激酶分子库 临床前化合物库 抗乳腺癌化合物库 代谢化合物库 抗癌化合物库 抗生素库 细胞骨架化合物库 大环化合物库

剂量换算

对于不同动物的给药剂量换算,您也可以参考 更多...

体内实验配液计算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。

第一步:请输入动物实验的基本信息
剂量
mg/kg
每只动物体重
g
给药体积
μL
动物数量
第二步:请输入动物体内配方组成,不同的产品配方组成不同,如有配方需求,可先联系我们提供正确的体内配方。
% DMSO
%
% Tween 80
% ddH2O
计算 重置

技术支持

您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。

Keywords

Geldanamycin 30562-34-6 Cytoskeletal Signaling Metabolism Microbiology/Virology Tyrosine Kinase/Adaptors HSP Influenza Virus Tyrosine Kinases Antibacterial Antibiotic NSC-122750 Bacterial NSC122750 inhibit 格尔德霉素 Inhibitor NSC 122750 Heat shock proteins inhibitor

 

陶术
生物
TargetMol®中国区唯一合作伙伴
点击进入陶术生物官网陶术生物
联系我们
400-820-0310

上海市静安区江场三路238号8楼